ReNeuron Group Company
ReNeuron Group engages in R&D and the commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications.
Acquisitions Number:
1
Founded Date:
01.01.1997
Last Funding Type:
Post-IPO Equity
Headquarters:
Guildford, Surrey, United Kingdom
Investors Number:
4
Technology:
Cell Therapy
Employee Number:
51-100
Industry:
Biotechnology
Estimated Revenue:
$1M to $10M
Last Funding Date:
10.07.2015
Number Of Exists:
Post-IPO Equity
Funding Status:
IPO
Investor Type:
Company
Investment Stage:
N/A
Total Funding:
167 333 065